Is Prostate Cancer Screening Bad or Good? Summary of a Debate at the Innovation in Urology Meeting, September 17-19, 2010, Milan, Italy

被引：6
作者：
Roobol, Monique J. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Urol, NL-3000 CA Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2011年 / 59卷 / 03期
关键词：
DIGITAL RECTAL EXAMINATION; MORTALITY; ANTIGEN; TRIAL; INTERVALS; NG/ML; ERSPC; MEN; PSA;
D O I：
10.1016/j.eururo.2010.10.036
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 362
页数：4
相关论文
共 31 条
[1]   Mortality Results from a Randomized Prostate-Cancer Screening Trial [J].
Andriole, Gerald L. ;
Grubb, Robert L., III ;
Buys, Saundra S. ;
Chia, David ;
Church, Timothy R. ;
Fouad, Mona N. ;
Gelmann, Edward P. ;
Kvale, Paul A. ;
Reding, Douglas J. ;
Weissfeld, Joel L. ;
Yokochi, Lance A. ;
Crawford, E. David ;
O'Brien, Barbara ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hayes, Richard B. ;
Kramer, Barnett S. ;
Izmirlian, Grant ;
Miller, Anthony B. ;
Pinsky, Paul F. ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) :1310-1319
[2]  
[Anonymous], 2006, SEER cancer statistics review, 1975-2003
[3]   Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria [J].
Bartsch, G ;
Horninger, W ;
Klocker, H ;
Reissigl, A ;
Oberaigner, W ;
Schönitzer, D ;
Severi, G ;
Robertson, C ;
Boyle, P .
UROLOGY, 2001, 58 (03) :417-424
[4]   Population-based case-control study of PSA and DRE screening on prostate cancer mortality [J].
Bergstralh, Eric J. ;
Roberts, Rosebud O. ;
Farmer, Sara A. ;
Slezak, Jeffrey M. ;
Lieber, Michael M. ;
Jacobsen, Steven J. .
UROLOGY, 2007, 70 (05) :936-941
[5]   Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer [J].
Carter, HB ;
Epstein, JI ;
Chan, DW ;
Fozard, JL ;
Pearson, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1456-1460
[6]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290
[7]   The effectiveness of screening for prostate cancer - A nested case-control study [J].
Concato, J ;
Wells, CK ;
Horwitz, RI ;
Penson, D ;
Fincke, G ;
Berlowitz, DR ;
Froehlich, G ;
Blake, D ;
Vickers, MA ;
Gehr, GA ;
Raheb, NH ;
Sullivan, G ;
Peduzzi, P .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (01) :38-43
[8]   Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].
Draisma, G ;
Boer, R ;
Otto, SJ ;
van der Cruijsen, IW ;
Damhuis, RAM ;
Schröder, FH ;
de Koning, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878
[9]  
Eckersberger Elisabeth, 2009, Rev Urol, V11, P127
[10]   PROSTATE-CANCER SCREENING IN THE PROSTATE, LUNG, COLORECTAL AND OVARIAN-CANCER SCREENING TRIAL OF THE NATIONAL-CANCER-INSTITUTE [J].
GOHAGAN, JK ;
PROROK, PC ;
KRAMER, BS ;
CORNETT, JE .
JOURNAL OF UROLOGY, 1994, 152 (05) :1905-1909
1234